Meeting on IGA Nephropathy

The National Kidney Foundation’s and IgA Nephropathy Foundation’s patient focused drug development (EL-PFDD) meeting on IgA Nephropathy was held on August 19, 2019.  Click here to go to the NKF Meeting Recording.


About EL-PFDD Meetings

Externally-led Patient-focused Drug Development (EL-PFDD) meetings bring together patients and their care-partners, representatives from the Food and Drug Administration (FDA), pharmaceutical companies interested in developing drugs for the disease, and doctors who are experts in the particular disease- all to hear from patients about the disease in question. In these meetings, the patient’s experience is brought to the forefront for the FDA and pharmaceutical companies to understand. “Externally-led” refers to PFDD meetings that are led by organizations outside of the FDA.